The dopamine hypothesis states that aberrant dopamine neuron activity underlies psychosis symptoms, yet currently available antipsychotics that target dopamine D2 receptors are not always effective and often result in intolerable side effects (i.e., dyskinesias and metabolic disorders; Lieberman et al., 2005). Here, DRD2 is linked to drug-induced dyskinesia.